Medikamentös-induzierte Polyneuropathien durch
                    Chemotherapeutika und Antiinfektiva

Pascal Achenbach; Frank Block; Manuel Dafotakis

doi:10.1055/a-1869-3577

Klinische Neurophysiologie, Table of Contents

Klinische Neurophysiologie 2022; 53(03): 159-173
DOI: 10.1055/a-1869-3577

CME-Fortbildung

Medikamentös-induzierte Polyneuropathien durch Chemotherapeutika und Antiinfektiva

Drug-Induced Polyneuropathies Associated with Chemotherapeutic Agents and Anti-infectives

Pascal Achenbach

,

Frank Block

,

Manuel Dafotakis

Abstract

Polyneuropathien können durch zahlreiche Wirkstoffe hervorgerufen oder aggraviert werden. Insbesondere die Chemotherapeutika-induzierte Polyneuropathie (CIPN) ist im Alltag von hoher Relevanz. Jedoch kann auch der Einsatz von Antiinfektiva zu neuropathischen Beschwerden führen. Im Folgenden soll ein Überblick über die wichtigsten mit Polyneuropathien assoziierten Wirkstoffe der Substanzklassen sowie die klinischen Charakteristika gegeben werden.

Abstract

Polyneuropathies are associated with numerous medications. Chemotherapy-induced polyneuropathy (CIPN) is highly relevant in clinical routine. However, treatment with anti-infectives can also lead to neuropathic symptoms. Here, we provide an overview of the most relevant drugs of these substance classes associated with polyneuropathies as well as the clinical characteristics.

Schlüsselwörter

Chemotherapie - Antibiotikum - Polyneuropathie - Nebenwirkung - Antiinfektiva

Key words

chemotherapy - antibiotic - polyneuropathy - side effect - anti-infectives

Full Text

References

Literatur
1 Jain KK. Drug-induced neurological disorders. 4. Auflage. Schweiz: Springer; 2021
2 Block F, Prüter C. Medikamentös induzierte neurologische und psychiatrische Störungen. Heidelberg: Springer Medizin Verlag; 2006
3 England JD, Asbury AK. Peripheral neuropathy. Lancet 2004; 363: 2151-2161
4 Grantz M, Huan MC. Unusual peripheral neuropathies. Part I: extrinsic causes. Semin Neurol 2010; 30: 387-395
5 Kushlaf HA. Emerging toxic neuropathies and myopathies. Psychiatr Clin North Am 2013; 36: 209-218
6 Li Y. Axonal sensorimotor polyneuropathies. Continuum (Minneap Minn) 2017; 23: 1378-1393
7 Little AA, Albers JW. Clinical description of toxic neuropathies. Handb Clin Neurol 2015; 131: 253-296
8 Manji H. Toxic neuropathy. Curr Opin Neurol 2011; 24: 484-490
9 McCorquodale D, Smith AG. Clinical electrophysiology of axonal polyneuropathies. Handb Clin Neurol 2019; 161: 217-240
10 Pratt RW, Weimer LH. Medication and toxin-induced peripheral neuropathy. Semin Neurol 2005; 25: 204-216
11 Toledano M. Toxin-induced neuropathies. Neurol Clin 2020; 38: 749-763
12 Umapathi T, Chaudhry V. Toxic neuropathy. Curr Opin Neurol 2005; 18: 574-580
13 Jones MR, Urits I, Wolf J. et al. Drug-induced peripheral neuropathy: a narrative review. Curr Clin Pharmacol 2020; 15: 38-48
14 Manji H. Drug-induced neuropathies. Handb Clin Neurol 2013; 115: 729-742
15 Jin PH, Shin SC. Neuropathy of connective tissue diseases and other systemic diseases. Semin Neurol 2019; 39: 651-668
16 Pestronk A. Toxic neuropathies. 2022 Im Internet: https://neuromuscular.wustl.edu/nother/toxic.htm (Stand: 29.06.2022)
17 Valentine WM. Toxic peripheral neuropathies: agents and mechanisms. Toxicol Pathol 2020; 48: 152-173
18 Cioroiu C, Weimer LH. Update on chemotherapy-induced peripheral neuropathy. Curr Neurol Neurosci Rep 2017; 17: 47
19 Staff NP, Grisold A, Grisold W. et al. Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 2017; 81: 772-781
20 Karam C, Dyck PJ. Toxic neuropathies. Semin Neurol 2015; 35: 448-457
21 Niimi N, Takaku S, Yako H. et al. Drug-induced demyelinating neuropathies. Adv Exp Med Biol 2019; 1190: 357-369
22 Grisold W, Carozzi VA. Toxicity in peripheral nerves: an overview. Toxics 2021; 9: 218 PMID: 34564369; PMCID: PMC8472820
23 Diezi M, Buclin T, Kuntzer T. Toxic and drug-induced peripheral neuropathies: updates on causes, mechanisms and management. Curr Opin Neurol 2013; 26: 481-488
24 Weimer LH, Sachdev N. Update on medication-induced peripheral neuropathy. Curr Neurol Neurosci Rep 2009; 9: 69-75
25 Peltier AC, Russell JW. Advances in understanding drug-induced neuropathies. Drug Saf 2006; 29: 23-30
26 Finsterer J, Löscher WN, Wanschitz J. et al. Orphan peripheral neuropathies. J Neuromuscul Dis 2021; 8: 1-23
27 Weimer LH. Medication-induced peripheral neuropathy. Curr Neurol Neurosci Rep 2003; 3: 86-92
28 Stübgen JP. Drug-induced dysimmune demyelinating neuropathies. J Neurol Sci 2011; 307: 1-8